CardioRenal is a company dedicated to improving the quality of treatment for heart failure patients through the use of state-of-the art technology (expert systems, real-time diagnosis, microfluidics, etc.) combined with top medical expertise.
CardioRenal est une société qui développe une solution de télé-médecine qui permet de mesurer des biomarqueurs chez un patient à domicile et ainsi d'adapter en temps réel la thérapie en fonction de l'état du patient. Nous ciblons les patients insuffisants cardiaques. Grâce à un accord de licence avec un laboratoire pharmaceutique nous visons une commercialisation à grande échelle à relativement court terme.
CardioRenal est une société qui développe une solution de télé-médecine qui permet de mesurer des biomarqueurs chez un patient à domicile et ainsi d'adapter en temps réel la thérapie en fonction de l'état du patient. Nous ciblons les patients insuffisants cardiaques. Grâce à un accord de licence avec un laboratoire pharmaceutique nous visons une commercialisation à grande échelle à relativement court terme.
Location: France, Grand Est, Strasbourg
Employees: 11-50
Total raised: $3.63M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Incubateur... | incubateur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.04.2022 | Seed | $3.63M | - |
Mentions in press and media 3
| Date | Title | Description |
| 04.04.2022 | CardioRenal Raises €3.3M in Seed Funding | CardioRenal, a Grenoble, France-based company that specializes in improving treatment at home for patients with severe chronic kidney disease (CKD), raised 3.3M in seed funding. The backers included French entrepreneurs and longstanding com... |
| 04.04.2022 | French platform raises €3.3 million to roll out device for monitoring patients suffering from kidney failure at home | Globally, around 700 million people live with chronic kidney disease (CKD), with many more likely still undiagnosed. These patients frequently have fluctuating blood potassium levels, which exposes them to possible cardiac complications. Th... |
| - | French platform raises €3.3 million to roll out device for monitoring patients suffering from kidney failure at home | Globally, around 700 million people live with chronic kidney disease (CKD), with many more likely still undiagnosed. These patients frequently have fluctuating blood potassium levels, which exposes them to possible cardiac complications. Th... |